https://www.selleckchem.com/products/MK-2206.html
Societal costs per patient decreased over 50% during the observation period (€2 800 to €120. The number of sleep apnoea patients in Finland increased remarkably during the observation period. To control this burden, diagnostic methods and treatment were revised and follow up was reorganised. Consequently, there was a significant decrease in societal costs per patient. The decrease in disability pensions suggests earlier diagnosis and improved treatment. The national sleep apnoea programme was one of the initiators for these improved o
Like
Comment
Share
